Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Gene Therapy to Enhance Levodopa Response Progressing in Clinical Trials

    New Parkinson’s Drug Formulation Shows Positive Phase III Trial Results

    In a Phase III clinical trial, Neuroderm’s liquid, under-the-skin levodopa/carbidopa controls symptoms better than levodopa pills in people with progressing Parkinson’s.
    Learn more
  • Doctor and two people in clinic room

    Research Roundup: Recruiting Studies for Better Parkinson’s Treatment

    The Michael J. Fox Foundation shares studies recruiting volunteers aimed to treat Parkinson’s.
    Learn more
  • Lab tech performs research in a lab

    What We Fund: $30M Toward Innovative Parkinson’s Diagnostic Tools and Disease Modifying Therapies

    The Michael J. Fox Foundation announces 57 grants that total more than $30 million to studies that advance Parkinson’s research and validate targeted therapies.
    Learn more
  • Equipment at a doctor's office

    New Study Shows the Incidence of Parkinson’s in the U.S. Is Nearly 50 Percent Higher than Previous Estimates

    A new study shows the annual incidence of Parkinson’s disease among older adults in the U.S. is nearly 50 percent higher than previous estimates.
    Learn more
  • Brain scan

    Glove Shows Potential to Ease Parkinson’s Motor Symptoms

    Researchers at Stanford Medicine have developed a glove aimed at alleviating motor symptoms caused by Parkinson’s disease (PD). Here's what people in the PD community need to know about the…
    Learn more
  • Pharma Company Buys Up MJFF-funded Biotech and Motor Symptom Therapy

    Filling Out the Roster of Parkinson’s Disease Therapies

    We review different kinds of therapeutic approaches in testing to slow or stop Parkinson’s disease with some examples of each.
    Learn more
  • PDTC 2022

    Parkinson’s Disease Therapeutics Conference Showcases Progress Toward Better Treatments

    The Michael J. Fox Foundation (MJFF) hosted the world’s only conference focused entirely on Parkinson’s disease (PD) therapeutics in New York City on October 13.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.